New York legislation · 2025-2026 General Assembly
New York A11655: Establishes a rare kidney disease screening pilot program
Status: In committee, July 29, 2026
Establishes a rare kidney disease screening pilot program within the department of health to operate in at least two counties or regions in the state, targeting at-risk populations, to improve early diagnosis of RKD, connect patients with treatments and care, and evaluate the effectiveness and scalability of state-based RKD screening initiatives.
What the bill says
An act to amend the public health law, in relation to establishing a rare kidney disease screening pilot program; and providing for the repeal of such provisions upon expiration thereof.
From the introduced text, July 29, 2026:
AN ACT to amend the public health law, in relation to establishing a rare kidney disease screening pilot program; and providing for the repeal of such provisions upon expiration thereof THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 207-b to read as follows: § 207-B. RARE KIDNEY DISEASE SCREENING PILOT PROGRAM. 1. DEFINITIONS. FOR THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (A) "RARE KIDNEY DISEASE" OR "RKD" MEAN, WITHOUT LIMITATION, THE FOLLOWING CONDITIONS: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), IGA NEPHROPATHY, C3 GLOMERULOPATHY, MEMBRANOUS NEPHROPATHY, ALPORT SYNDROME, AND OTHER NON-DIABETIC, NON-HYPERTENSIVE FORMS OF CHRONIC KIDNEY DISEASE IDENTIFIABLE THROUGH URINALYSIS, GENETIC TESTING, OR RELATED DIAGNOSTICS. (B) "AT-RISK POPULATIONS" MEANS COMMUNITIES WITH STATISTICALLY HIGHER INCIDENCES OF RKD OR KIDNEY FAILURE, INCLUDING BUT NOT LIMITED TO AFRICAN AMERICAN, ASIAN AMERICAN, AND HISPANIC COMMUNITIES, AND POPULATIONS WITH LIMITED ACCESS TO SPECIALTY CARE. (C) "PROGRAM" MEANS THE RARE KIDNEY DISEASE SCREENING PILOT PROGRAM ESTABLISHED PURSUANT TO SUBDIVISION TWO OF THIS SECTION. 2. ESTABLISHMENT. THE DEPARTMENT SHALL ESTABLISH A RARE KIDNEY DISEASE SCREENING PILOT PROGRAM, TO OPERATE IN AT LEAST TWO COUNTIES OR GEOGRAPHIC REGIONS WITHIN THE STATE, TARGETING AT-RISK POPULATIONS. THE PURPOSE OF SUCH PILOT PROGRAM SHALL BE TO …
Sponsors
- Yudelka Tapia (D, 86) · primary sponsor
Latest actions
- : REFERRED TO HEALTH
Subjects: Public Health Law
Common questions
- What is A11655?
- A11655 is a bill in the New York Legislature (2025-2026 General Assembly): Establishes a rare kidney disease screening pilot program.
- What does A11655 do?
- In its own words: An act to amend the public health law, in relation to establishing a rare kidney disease screening pilot program; and providing for the repeal of such provisions upon expiration thereof.
- What is the status of A11655?
- In committee as of July 29, 2026. Latest action: REFERRED TO HEALTH (July 29, 2026).
- Who sponsored A11655?
- Yudelka Tapia (D, 86).
- Where is the official record for A11655?
- On the New York Legislature website: https://www.nysenate.gov/legislation/bills/2025/A11655
Source: official New York record. Tracked by Delilah, AI for legislation across all 50 states and Congress.